Results 41 to 50 of about 316,739 (266)
Nutrition Bulletin, EarlyView.ABSTRACT The British Nutrition Foundation and Quadram Institute hosted a multidisciplinary roundtable, chaired by Professor Jessica Fanzo, to explore how the UK food system can be transformed to achieve net zero targets while ensuring nutritional adequacy, food security, and health equity across the life course. Current dietary patterns are significant
A. Spiro +5 more
wiley +1 more source
Health Science Reports, Volume 8, Issue 10, October 2025.ABSTRACT Background and Aims Vitiligo is a long‐lasting depigmenting disorder that has a significant impact on people's emotional health but does not cause physical impairment. They deal with high levels of anxiety, depression, and stress. Physical activity (PA) is one of the potentially protective factors against psychological disorders, but its role ...
Zeinab Aryanian +6 more
wiley +1 more source
Clinical Oral Implants Research, Volume 36, Issue 10, Page 1234-1247, October 2025.ABSTRACT Objectives This study assessed 12‐month post‐loading 3D peri‐implant radiographic bone changes in osteoporotic women receiving a single titanium‐zirconium bone‐level tapered dental implant with a hydrophilic surface. Materials and Methods This was a prospective case series involving 18 post‐menopausal osteoporotic women in need of a single ...
Calciolari Elena +4 more
wiley +1 more source
Journal of Medical Case Reports, 2014 IntroductionAcute portomesenteric vein thrombosis is an uncommon but serious condition with potential sequelae, such as small-bowel gangrene and end-stage hepatic failure.
P. Venkatesh +4 more
semanticscholar +1 more source
Autoantibodies and Inflammation in Schizophrenia
Psychiatry and Clinical Neurosciences, Volume 79, Issue 10, Page 611-618, October 2025.The potential role of autoantibodies in the etiology of schizophrenia is a key research focus because growing evidence suggests an association between immune dysfunction and psychotic disorders. This hypothesis is supported by findings indicating immune‐related abnormalities in patients with schizophrenia, including chronic inflammation and genetic ...
Hiroki Shiwaku
wiley +1 more source
Neurodevelopment and neural environment inform Alzheimer's disease age at onset and phenotype
Alzheimer's &Dementia, Volume 21, Issue 9, September 2025.Abstract INTRODUCTION Risk factors associated with sporadic non‐amnestic and early‐onset Alzheimer's disease (AD) remain underexamined. METHODS We investigated a large, clinically heterogeneous, AD cohort for frequencies of established risk factors (hypertension, hypercholesterolemia, diabetes mellitus) alongside novel factors (non–right‐handedness ...
Zachary A. Miller +27 more
wiley +1 more source
Carcinoïd tumor revealing pernicious anemia
The Pan African Medical Journal, 2014 Endocrine tumors (ET) of the digestive tract are rare. Gastric carcinoid was the most common form of gastrointestinal ET's. It is a rare complication of pernicious anemia but may reveal the disease.
Neirouz Ghannouchi Jaafoura +1 more
doaj +1 more source
COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
JEADV Clinical Practice, Volume 4, Issue 4, Page 811-820, September 2025.Guidelines for alopecia areata recommend that baseline investigations are unnecessary, but is this standard practice among hair loss experts worldwide? This global study showed high rates of laboratory testing of patients with alopecia areata, particularly related to autoimmune co‐morbidities.
Cathal O'Connor +39 more
wiley +1 more source
Journal of the Formosan Medical Association, 2020 Background/Purpose: Our previous study found that 56 of 1064 atrophic glossitis (AG) patients have vitamin B12 deficiency. This study assessed whether the AG patients with vitamin B12 deficiency (B12D/AG patients) had significantly higher frequencies of ...
Yang-Che Wu +5 more
doaj +1 more source
British Journal of Haematology, Volume 207, Issue 2, Page 387-394, August 2025.Individuals who may develop multiple myeloma within 5 years. Stage I (left) identifies patient and control groups and variables that differ between them. Stage II (middle) develops a complex SGBOOST model to predict future MM patients. Stage III (right) develops a simplified model.
Moshe Mittelman +8 more
wiley +1 more source